The Use of Pentoxifylline and Vitamin E in the Treatment of Late Radiation Related Injuries
A Phase II Study of the Use of Pentoxifylline and Vitamin E in the Treatment of Late Radiation Related Injuries
Sponsor: Princess Margaret Hospital, Canada
Listed as NCT00188552, this PHASE2 trial focuses on Wounds and Injuries and remains terminated or withdrawn. Sponsored by Princess Margaret Hospital, Canada, it has been updated 5 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2
First recorded
Jul 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Princess Margaret Hospital, Canada
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Toronto, Canada